Trial intelligence / Profile preview

The Effect of Polynucleotide on Facial Skin Microbiome

TCTR20260701011Phase 2Active, not recruiting

Sponsor
N/A
Start
Jun 2026
Countries
1
01

Overview

A Phase 2 trial of polydeoxyribonucleotide in Facial Dermatosis, sponsored by N/A. Started Jun 2026; status: active, not recruiting.

02

Drugs

polydeoxyribonucleotide
03

Conditions

Facial Dermatosis

Beyond the preview

Go deeper on TCTR20260701011.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on TCTR20260701011.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call